View of Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors | Upsala Journal of Medical Sciences

Return to Article Details Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors